Modeling the Iatrogenic Pancreatic Cancer Risk After Islet Autotransplantation in Mouse

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
E DugnaniL Piemonti

Abstract

Iatrogenic pancreatic cancer metastasis after islet infusion is a potential risk of islet autotransplantation performed after pancreatectomy. To model this risk, islets and/or pancreatic exocrine clusters obtained from a genetically engineered mouse model for pancreatic ductal adenocarcinoma (the LSL-KrasG12D/+ ;LSL-Trp53R172H/+ ;Pdx-1-Cre, termed KPC mouse) were transplanted via the portal vein in syngeneic wild type (WT) severely diabetic recipients in the following treatment groups: group A (n = 11) received KPC exocrine clusters in volume equal to 250 islet equivalents (IEQs); group B (n = 12) received 250 WT IEQs mixed with KPC exocrine clusters (1:1 volume ratio); group C (n = 5) received 250 KPC IEQs, and group D (n = 7) received 250 WT IEQs. The incidence of hepatic metastasis was assessed by magnetic resonance imaging and histology over the 13 months of follow-up. Overall survival was not different in the four groups. No mice developed liver metastases during the follow-up. Two mice developed spontaneous tumors: a liver hepatocellular tumor in group A and a malignant lymphoma in group D. Islets and/or exocrine clusters obtained by KPC mouse, a model that develops pancreatic cancer with 100% penetrance, do not retain th...Continue Reading

References

May 20, 1993·The New England Journal of Medicine·A B LowenfelsL Domellöf
Mar 19, 1997·Journal of the National Cancer Institute·A B LowenfelsD C Whitcomb
Apr 7, 2007·The American Journal of Surgical Pathology·Arnold M Schwartz, Donald E Henson
Feb 20, 2008·Langenbeck's Archives of Surgery·Jan-Bart M KoorstraAnirban Maitra
Mar 9, 2012·Journal of the American College of Surgeons·David E R SutherlandTimothy L Pruett
Mar 22, 2012·The British Journal of Surgery·K BramisA R Dennison
Mar 6, 2013·The American Journal of Gastroenterology·Gabriele CapursoUNKNOWN Intraductal Papillary Mucinous Neoplasm (IPMN) Study Group
Jun 12, 2013·Annals of Surgical Oncology·Ioannis T KonstantinidisPeter J Allen
Jun 12, 2013·Annals of Surgery·Gianpaolo BalzanoLorenzo Piemonti
Mar 25, 2014·Journal of the American College of Surgeons·Srinath ChinnakotlaTimothy L Pruett
May 2, 2014·BioMed Research International·M DistlerRobert Grützmann
Jun 12, 2014·Current Diabetes Reports·Gianpaolo Balzano, Lorenzo Piemonti
Jan 20, 2015·Annals of Surgery·Melena D BellinDana K Andersen
Dec 24, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G BalzanoL Piemonti
May 4, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S MuratoreG Beilman
Aug 25, 2016·Acta Diabetologica·Erica DugnaniLorenzo Piemonti

❮ Previous
Next ❯

Citations

Aug 17, 2018·Transplantation·Florence RenaudFrançois Pattou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.